Intravenous immunoglobulin: recent advances in the treatment of autoimmune bullous diseases

被引:0
|
作者
Daniel, B. S. [1 ,2 ]
Murrell, D. F. [1 ,2 ]
机构
[1] St George Hosp, Dept Dermatol, Sydney, NSW 2217, Australia
[2] Univ New S Wales, Sydney, NSW, Australia
来源
关键词
Skin diseases; vesiculobullous; Autoimmunity; MUCOCUTANEOUS BLISTERING DISEASES; GAMMA-GLOBULIN; PEMPHIGUS FOLIACEUS; ADJUVANT THERAPY; IMMUNE GLOBULIN; IGA; MANAGEMENT; DERMATOSES; ANTIBODIES; CHILDHOOD;
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Autoimmune bullous diseases describes a heterogenous group of diseases with skin and mucosal involvement with varying degrees of mortality. Intravenous immunoglobulin (IVIg) is a specialised treatment used in the management of these AIBD with variable success. This paper outlines the use of IVIg in these diseases.
引用
收藏
页码:259 / 267
页数:9
相关论文
共 50 条